Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study. | Ther Adv Neurol Disord | 2026 | 41726319 | PubTator, text mining | PubMed |
| Application of nanoparticles in antibody drug delivery. | Front Bioeng Biotechnol | 2026 | 41725956 | PubTator, text mining | PubMed |
| Myasthenia Gravis With Acetylcholine Receptor Antibodies in the Very Old: Treatment Challenges and Diagnostic Pitfalls. | Eur J Neurol | 2026 | 41721543 | PubTator, text mining | PubMed |
| Association between maternal anti-Ro and anti-La antibody levels and congenital heart block: a 20-year cohort study. | Arch Gynecol Obstet | 2026 | 41721052 | PubTator, text mining | PubMed |
| The complex patent situation regarding antibody Fc engineering. | J Biotechnol | 2026 | 41720268 | PubTator, text mining | PubMed |
| Transplacental Antibody Transfer: Mechanisms, Pregnancy-Related Disruptions, and Emerging Experimental Models. | Antibodies (Basel) | 2026 | 41718402 | PubTator, text mining | PubMed |
| The role and mechanism of IL‑35 in myasthenia gravis (Review). | Int J Mol Med | 2026 | 41716022 | PubTator, text mining | PubMed |
| Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges. | Anal Chem | 2026 | 41712472 | PubTator, text mining | PubMed |
| What is refractory CIDP? | BMJ Neurol Open | 2026 | 41710927 | PubTator, text mining | PubMed |
| GB20-5A8-31, an anti-TL1A antibody for treating inflammatory bowel disease. | Front Immunol | 2026 | 41710891 | PubTator, text mining | PubMed |
| Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study. | J Neurol | 2026 | 41699286 | PubTator, text mining | PubMed |
| Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safety. | Ther Adv Neurol Disord | 2026 | 41696674 | PubTator, text mining | PubMed |
| Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report. | Thyroid | 2026 | 41684304 | PubTator, text mining | PubMed |
| Abstracts of the EUGOGO Global TED Forum 2025. | Thyroid Res | 2026 | 41673872 | PubTator, text mining | PubMed |
| Stereochemical and Structural Characterization of Methionine Oxidation in the IgG1 Fc Region by Integrated NMR and LC-MS Analysis. | Anal Chem | 2026 | 41670217 | PubTator, text mining | PubMed |
| Real-world use of efgartigimod in acetylcholine receptor antibody-positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus. | Front Neurol | 2026 | 41648665 | PubTator, text mining | PubMed |
| Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses. | Alzheimers Dement | 2026 | 41639038 | PubTator, text mining | PubMed |
| Delayed recovery following myasthenic exacerbation and subsequent endplate-protecting treatment. | Neurol Sci | 2026 | 41634421 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screening identifies Annexin A1 as a facilitator of porcine astrovirus entry. | PLoS Pathog | 2026 | 41628256 | PubTator, text mining | PubMed |
| Efgartigimod for steroid-resistant autoimmune glial fibrillary acidic protein astrocytopathy: a case report and literature review. | J Neuroimmunol | 2026 | 41610721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=10